Background Recombinant adenovirus can be administered in vivo to achieve transduction of a number of cell types including human synoviocytes. Immunogenicity of adenoviruses has limited their utility as vectors for gene delivery; however, specific mechanisms underlying the acute inflammatory response to adenovirus are not well understood. Activation of a number of signal transduction pathways occurs rapidly upon adenovirus binding to cellsurface receptors. We investigated stimulated expression of mitogen-activated protein kinases (MAPKs), cyclooxygenase-2 (COX-2) and prostaglandin E 2 (PGE 2 ) in human primary synovial fibroblasts to adenovirus expressing the E. coli β-galactosidase gene.
Introduction
Recombinant adenoviruses can be administered in vivo to achieve transduction of a number of cell types including synoviocytes, chondrocytes and fibroblasts [1] [2] [3] [4] [5] . Recombinant adenoviruses have advantageous features for in vivo administration including the ability to infect non-dividing cells and high efficiencies of transgene expression [6] [7] [8] . It has been posited that transduction of synovial cells in vivo with recombinant adenoviruses to induce overexpression of antiinflammatory or immunomodulatory proteins may be an innovative approach to the treatment of rheumatic diseases. Several groups have reported pre-clinical animal studies using in vivo administration of recombinant adenoviruses that represent models of intra-articular gene therapy for rheumatic diseases [9] [10] [11] [12] [13] [14] [15] .
Immunogenicity is a significant limitation to the in vivo administration of recombinant adenovirus. An acute host immune response occurs rapidly following parenteral administration of virus and, in the case of intravascular injection, the sequelae can be catastrophic [16] . The viral capsid and genome (via expression of viral proteins) are both important mediators of the immune response to adenovirus [8, [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] .
The specific mechanisms underlying the acute inflammatory response to adenovirus infection are not completely understood. Activation of a number of signal transduction pathways occurs rapidly upon adenovirus binding to cell-surface receptors. Adenovirus capsids interact with both the Coxsackie adenovirus receptor (CAR) and the α v β 3 and α v β 5 integrins via the fiber knob protein and the penton protein RGD motifs, respectively. Expression of CAR correlates with the ability of adenovirus to infect target cells in a number of cell systems [28] [29] [30] [31] [32] . CAR is composed of an extracellular domain containing two disulfide-linked loops, a hydrophobic transmembrane domain, and a cytoplasmic domain. Functional analysis demonstrated that despite conservation of the cytoplasmic domain, the extracellular domain is sufficient to permit virus attachment [29, 33] . Since the cytoplasmic domain of CAR is not required for virus entry, it is likely that other cell-surface receptors are critical for signaling events stimulated by adenovirus infection. The α v integrins have been shown to facilitate internalization into cells [34] . Adenovirus internalization and infection is inhibited by the penton base, soluble RGD peptides, and function-blocking monoclonal antibodies directed against the α v β 3 and α v β 5 integrins [34] . It was subsequently shown that these cell-surface integrins, particularly α v β 5 , are necessary for efficient adenovirus-mediated gene transfer [35] [36] [37] [38] [39] .
Viral entry and nuclear localization have been shown to require the preservation of key signaling pathways and the induction of cell changes that mimic those seen in response to growth factors and integrins [40] . Viral endocytosis is dependent on phosphatidylinositol-3-OH kinase (PI3-kinase) activity, the small GTPases RacI and Cdc42, phosphorylation of p130 Crk-associated substrate (p130 CAS ), and alterations in the actin cytoskeleton [41] [42] [43] . Activation of intracellular signaling pathways is also critical for the nuclear targeting of adenovirus. Adenovirus activates two distinct pathways, protein kinase A and p38 mitogen-activated protein kinase (MAPK), to facilitate transport to the nucleus [44] .
The MAPK signaling pathways also play important roles in regulating gene expression [45] . The MAPKs include extracellular signal related kinases (ERK)-1 and -2, c-Jun N-terminal kinase (JNK), and p38. ERKs are typically activated by mitogens such as growth factors and hormones, while JNK and p38 are stimulated by stress stimuli including pro-inflammatory cytokines. Receptor-associated GTP transfer proteins (GTPases) trigger a cascade of protein kinases beginning with MAP kinase kinase kinases (MAPKKK), which activate MAP kinase kinases (MAPKK) by serine and threonine phosphorylation. MAPKKs are dual-specificity kinases that phosphorylate MAPKs on threonine and tyrosine residues. Once activated, MAPKs can directly phosphorylate transcription factors or transcriptional co-regulators or phosphorylate downstream kinases that also regulate transcription and mRNA stability.
Among the genes activated via MAPK signaling pathways is the inducible form of cyclooxygenase (COX), COX-2, by stimulating transcription and increasing mRNA stability [46] [47] [48] [49] [50] [51] [52] . COX is the pivotal enzyme responsible for conversion of arachidonic acid to prostaglandins. There are two isoforms of COX, COX-1 and COX-2. COX-1 is constitutively expressed in most cell types while the basal expression of COX-2 is highly restricted. COX-2 is rapidly up-regulated by many different inflammatory, mitogenic, and stress stimuli [53] . In most inflammatory settings including arthritis, prostaglandin E 2 (PGE 2 ) is the most abundant product of the COX pathway [54] . PGE 2 has pleitropic activities mediated by binding to G-proteinlinked cell-surface receptors [55] . Injection of PGE 2 recapitulates the cardinal signs of acute inflammation via vasodilation with plasma extravasation and sensitization of nociceptors [56] . In addition to the role of PGE 2 in mediating classical inflammation, prostaglandins are important modulators of the innate immune system [57] .
The MAPK signaling pathways are thought to be involved in induced expression of some inflammatory mediators by adenovirus infection. For example, Bruder and Kovesdi reported that adenovirus infection stimulated activation of the Raf/MAPK pathway leading to rapid induction of IL-8 expression in HeLa cells [6] . The phosphorylation of MAPK and Raf occurred within 10-20 min and heat inactivation of the virus eliminated MAPK pathway activation.
We hypothesized that adenovirus infection of synoviocytes could directly induce expression of inflammatory mediators including COX-2-derived PGE 2 . In order to evaluate this hypothesis, we studied induction of signal transduction pathways and inflammatory mediator production in primary human synoviocytes from patients with rheumatoid arthritis (RA) after exposure to adenovirus expressing the gene for E. coli β-galactosidase. We now demonstrate that adenovirus infection induces expression of COX-2 and increases PGE 2 production. Furthermore, increased expression of these mediators is a result of activation of MAPK signaling pathways.
Materials and methods

Synoviocyte culture
Synovial tissues were obtained from patients with RA at the time of joint replacement surgery as approved by the institutional review board. Tissues were dissociated by mincing and then incubating in 4 mg/ml type I collagenase in Dulbecco's modified Eagle's medium (DMEM) for 4 h at 37 • C in an atmosphere containing 5% CO 2 [58] . Dissociated cells were cultured in DMEM supplemented with 10% human AB serum (Biowhittaker, Walkersville, MD, USA), 10% fetal bovine serum (Life Technologies, Grand Island, NY, USA), penicillin (100 units/ml), and streptomycin (100 µg/ml). Primary synoviocytes were used between the 3rd and 8th passages.
Adenoviral vector preparation
Replication-defective adenoviral vectors (type 5) were deleted of sequences spanning E1A, E1B (map units 1-9), and a portion of the E3 region (map units 83-85), impairing the ability of this virus to replicate or transform nonpermissive cells [5, 59] . In the vector Ad/RSVLacZ, the long terminal repeat of the Rous sarcoma virus drives transcription of the E. coli β-galactosidase (LacZ) gene with an SV40 polyadenylation sequence cloned downstream from the reporter [5] .
High titer recombinant adenovirus was prepared by amplification in the permissive 293 cell line using established methods [60] . Virus was purified from cell lysates twice by cesium chloride gradient ultracentrifugation followed by desalting on Sephadex G-50 columns with phosphate-buffered saline (PBS). Titers were determined by OD 260 , and were ∼1 × 10 13 particles/ml ± 1 log (1.0 OD unit = 1.0 × 10 12 particles/ml). The viral preparations were analyzed for their ability to form plaques on confluent 293 cell monolayers [61] . Approximately 1 in 100 virus particles were infection-competent.
Inactivation of Ad/RSVLacZ
Ultraviolet (UV) light treatment in the presence of 8-methoxypsoralen was used to inactivate Ad/RSVLacZ [22] . 8-Methoxypsoralen (8-MP, Sigma Chemical Co., St. Louis, MO, USA) was dissolved in dimethyl sulfoxide at 33 mg/ml and added to the high titer viral suspension to yield a final concentration of 330 µg/ml. The adenovirus with 8-MP was placed into a transparent container (Slide-A-Lyzer 10K dialysis cassette, Pierce, Rockford, IL, USA), exposed to UVA band light generated by a fluorescent tube at a distance of 1 cm above the virus. The UVA exposure was performed at 4 • C for a period of 30 min, resulting in an UVA dose of greater than 150 J/cm 2 . The container was rotated periodically to maintain adequate cooling and ensure even exposure of the particles. The virus was then dialyzed extensively against Tris-EDTA buffer, pH 8.0, to remove unincorporated psoralen. Confirmation of adenoviral genome inactivation was determined in 293 cells in a series of limiting dilution infections followed by X-gal staining 48 h following infection.
Synoviocyte infection
Synoviocytes (5 × 10 4 /well) were plated in 6-well plates the day prior to infection. Complete media was removed and cells were washed with PBS. Ad/RSVLacZ was added in 400 µl RPMI at a concentration of 10 4 transfectioncompetent virus particles per cell. Addition of virus was T = 0 for timed samples. Complete media to a final volume of 2 ml was added at 2 h after infection for longer incubations. MAPK inhibitors were added 10 min prior to addition of virus.
Reverse-transcription polymerase chain reaction (RT-PCR)
Total RNA was prepared by using Tri-Reagent (Molecular Research Center, Cincinnati, OH, USA). cDNA was prepared by reverse transcription as previously described [62] . PCR reactions were performed in 50 µl containing 5 µl cDNA (diluted 1 : 10 after reverse transcription of 5 µg total RNA), 10 mM Tris HCl (pH 8. 
Immunoblotting
Protein for COX-2 immunoblotting was collected in 1X PBS (pH 7.4), 5 mM EDTA (pH 8.0), 1% NP-40, 0.1% SDS, 0.5% deoxycholic acid, 1 mM phenylmethylsulfonyl fluoride, 10 µg/ml aprotinin, and 10 µg/ml leupeptin and incubated on ice for 10 min. Cells were sonicated at 30% power for 30 s. Protein concentrations were measured with the BioRad-DC kit (Hercules, CA, USA). Proteins (20 µg) were separated on a 10% Tris-glycine gel (Novex, San Diego, CA, USA) and transferred to an activated nylon membrane (PVDF-Plus, Micron Separations, Westborough, MA, USA). Equal protein loading was confirmed by staining with Ponceau S red (Sigma, Milwaukee, WI, USA). Membranes were blocked with 3% (weight/volume) Carnation nonfat dry milk in Tris-buffered saline (TBST, 150 mM NaCl, 20 mM Tris HCl, pH 7.6, and 0.1% TWEEN-20). Rabbit polyclonal antibody to human COX-2 (Cayman Chemical, Ann Arbor, MI, USA) was added in fresh blocking solution (1 : 1000) and incubated for 1 h at room temperature. Membranes were washed three times in TBST, incubated for 1 h with horseradish peroxidase-conjugated antirabbit immunoglobulin diluted 1 : 5000 in TBST, then washed as above. The enhanced chemiluminescence (ECL) system (Amersham, Arlington Heights, IL, USA) was used for detection. Membranes were stripped and re-probed with an antibody to β-actin (Sigma).
For analysis of phospho-ERK, phospho-p38 MAPK, phospho-JNK and unphosphorylated MAPK, cells were harvested in 50 mM Hepes (pH 7.4), 150 mM NaCl, 1 mM EGTA, 10 mM Na 4 P 2 O 7 , 100 mM NaF, 1% Triton X-100, 10% glycerol, 0.5% deoxycholic acid, 0.1% SDS, 50 mM β-glycerophosphate, 3 mM sodium vanadate (added fresh) and 10 µg/ml aprotinin (added fresh). Rabbit polyclonal anti-phospho-ERK1/2 (Promega, Madison, WI, USA), anti-phospho-p38 (Cell Signaling, Beverly, MA, USA), anti-phospho-JNK2 (Promega) antibodies directed against the unphosphorylated forms of ERK1/2, p38, and JNK (Santa Cruz Biotechnology, Santa Cruz, CA, USA) were used at a dilution of 1 : 1000. Procedures were otherwise the same as described above.
Enzyme-linked immunoassay (EIA)
PGE 2 was measured by EIA using a kit (Cayman Chemical, Ann Arbor, MI, USA) according to the manufacturer's instructions.
Statistical analysis
Autoradiographs were scanned and analyzed using NIH Image. Statistical comparisons were made using Student's t-test.
Results
Ad/RSVLacZ infection rapidly increases expression of inflammatory mediators in RA synoviocytes
Increased expression of COX-2 mRNA and protein was observed after infection with Ad/RSVLacZ (Figures 1  and 2 ). Elevated COX-2 transcripts were seen by 1 h after infection, and were maximal by 4 h. COX-2 protein levels were increased by 4 h and reached maximal levels by 8 h after infection with Ad/RSVLacZ. The time-course of COX-2 up-regulation was similar to that seen after treatment with pro-inflammatory cytokines such as IL-1β [62] . In Immunoblotting was performed for COX-2, then membranes were reprobed for β-actin. COX-2 was normalized to β-actin and the relative expression is shown. We demonstrate a significant increase in levels of COX-2 protein maximal at 8 h post-exposure to Ad/RSVLacZ ( * P < 0.01) addition to COX-2, we evaluated induction of IL-8 mRNA. Similar to previous reports, IL-8 transcript levels were maximal by 8 h and returned to baseline overnight (data not shown) [6] .
Transcription of adenoviral genes is not required for induction of inflammatory mediators
To determine if induction of inflammatory mediators was dependent on transcription of adenoviral genes, we compared induction of COX-2 by Ad/RSVLacZ before and after treatment with psoralen. Treatment with psoralen rendered the adenoviral DNA non-functional with respect to transcription while cell-surface binding and internalization were preserved. As shown in Figure 3 , increased COX-2 protein was observed by 4 h and reached a similar maximal level of expression by 8 h in both untreated and psoralen-treated adenovirus. At 24 h, 
Ad/RSVLacZ infection increases phosphorylation of MAPK
We evaluated potential signal transduction pathways for activation by Ad/RSVLacZ. We found that ERK and JNK were rapidly phosphorylated in RA synoviocytes after exposure to Ad/RSVLacZ, with increases that were statistically significant: P < 0.005 and P = 0.005, respectively ( Figure 4 ). P38 MAPK was also increased, but changes were not statistically significant. Maximum intensity was seen at 5-15 min after treatment.
Up-regulation of COX-2 is mediated by MAPK
Induction of COX-2 by Ad/RSVLacZ was blocked by pretreatment with PD98059, an inhibitor of the MAPKK MEK-1/2 which activates ERK, and SB203580, which blocks activity of p38 MAPK ( Figure 5 ). COX-2 levels were reduced by 66% by PD98059, 60% by SB2-3580, and Figure 6 . Inhibitors of MAPK block the adenovirus-stimulated increase of PGE 2 . Synoviocytes were exposed to adenovirus in the presence or absence of the MEK-1/2 inhibitor PD98059 (25 µM), the p38 MAPK inhibitor SB203580 (3 µM), or both, applied 10 min prior to treatment. Adenovirus exposure significantly increased PGE 2 levels ( * P < 0.001). Induced PGE 2 levels were reduced below baseline by either PD98059 ( * * P < 0.0001), SB203580 ( * * P < 0.0001), or both ( * * P < 0.0001). There was no additive effect for the combination. The results represent two experiments each tested for PGE 2 in duplicate 70% by the combination. In parallel with decreased COX-2 protein levels, PGE 2 production was also significantly reduced by pre-treatment with PD98059 and SB20358 (P < 0.0001) ( Figure 6 ). These data indicate that upregulation of COX-2 and increased PGE 2 are dependent, at least in part, on activation of MAPK.
Discussion
We demonstrated that Ad/RSVLacZ treatment of RA synoviocytes induces expression of COX-2 and subsequent generation of the key inflammatory mediator PGE 2 .
Because similar early patterns of COX-2 induction were observed with the administration of adenoviruscontaining transcriptionally inactivated genomes to synoviocytes, we conclude that early induction of COX-2 does not require transcription of adenoviral genes. Adenoviral entry into cells is mediated by signaling pathways activated by binding the α v integrins and requires MAPK pathway activation. Viral binding to synoviocytes results in activation of the MAPK family members, p42 ERK-1, p44 ERK-2, p38 MAPK, and JNK2. We speculate that binding of adenovirus to the α v integrins is the critical factor for activation of the MAPKs that upregulated COX-2. Preservation of the MAPK signaling pathways was necessary for activation of COX-2, and blockade of either the ERK or p38 pathways results in markedly diminished COX-2 expression and PGE 2 production. Similar to other stimuli for MAPK activation, stimulation by adenovirus binding occurs very rapidly but has sustained effects. It is likely that the MAPK cascade is important for production of a critical cellular protein and that blockade of the early signaling cascade is sufficient to block the program involved in generation of COX-2. It has previously been reported by Hirschowitz et al. that a first-generation ( E1, E3) adenoviral vector encoding a green fluorescent protein (GFP), prostatespecific antigen, or and a null vector induces COX-2 and PGE 2 in non-small-cell lung cancer cells [63] . These cells constitutively express COX-2 and relatively high levels of PGE 2 . High levels of COX-2 in some malignant cells are thought important for cellular invasion, induction of angiogenesis, altered apoptosis, and increased immunologic resistance [64] . Hirschowitz and colleagues reported that the COX-2 protein was induced at 48 h post-infection time points and that blockade of ERK prevented the increase in PGE 2 . In contrast to our results, they found that UV/psoralen-inactivated adenoviral vector did not increase PGE 2 levels. Differences between those data and the present report include differences in vector, the cell type examined, and the time points examined. Of interest, Zhang et al. reported that GFP itself can induce COX-2 and PGE 2 . Those authors reported that the increase in COX-2 and PGE 2 is mediated by up-regulation of HSP70 and independent of MAPK and phosphatidylinositol-3-kinase signaling cascades [65] . The increase in PGE 2 was sufficient to induce vasodilation.
The synoviocytes used in these experiments were derived from patients with rheumatoid arthritis. Although many of the characteristics of these cells are controlled by the in vivo milieu, these cells do retain some phenotypic characteristics in culture. For example, rheumatoid synoviocytes exhibit anchorage-independent growth in early passage and can destroy articular cartilage [66, 67] . In synoviocytes, COX-2 expression is stimulated by pro-inflammatory cytokines including IL-1β and TNF-α [62, [68] [69] [70] . The mechanisms leading to increased COX-2 expression by IL-1 include activation of NF-κB [62, 71] , translocation of c/EBP [72] , and activation of MAPK-dependent transcription factors. The data presented here suggest that infection with an adenoviral vector can also increase expression of COX-2. We showed that up-regulated COX-2 expression was associated with increased PGE 2 production after exposure to Ad/RSVLacZ in vitro. In support of these findings, Caromody et al. demonstrated an increase in COX-2 staining in calvarial tissues that was enhanced in animals receiving AdLacZ [73] . Of interest, AdLacZ also stimulated osteoclastogenesis in their experiments, known to be enhanced in the presence of PGE 2 .
In vivo, PGE 2 induces vasodilation, plasma extravasation, and sensitization of nociceptors [58] . In the context of adenovirus-based gene therapy administered locally for treatment of arthritis, stimulation of this pathway may not be of major clinical significance although it is difficult to predict the effects on joint tissues. However, similar regulatory pathways may be operative in vascular endothelial cells where regulation of COX-2 expression is similar to synovial cells. After intravascular administration, increased COX-2 expression and prostaglandin production may alter vascular tone and promote vascular leak syndromes.
Several gene therapy strategies have been employed using adenoviral-vector-based delivery of prostaglandin biosynthetic enzymes in vivo. The COX-1 gene alone or in a bicistronic construct with prostacyclin synthase resulted in augmented COX-1 and prostacyclin levels and reduced cerebrovascular infarct after intraventricular infusion [74] . They were unable to demonstrate increased COX-2 expression after adenovirus treatment. Another report demonstrated that adenovirally mediated expression of the inducible nitric oxide synthase proceeds by increased COX-2 as an obligatory downstream effector of cardioprotection after ischemia-reperfusion injury [75] . In that study, Ad5/LacZ control vector did not result in increased prostaglandin production in myocardial tissues, though it was unclear if there was an increase in COX-2 protein compared to an uninfected control.
IL-8 is a chemokine associated with infiltration of neutrophils and stimulation of angiogenesis in RA synovial tissues [76, 77] . Previous data demonstrated increased IL-8 mRNA expression by active and inactive AdLacZ by 20 min after infection in HeLa cells [6] . We confirmed those data in primary human synoviocytes. In HeLa cells, IL-8 was not affected by cyclohexamide or heat inactivation of the virus, suggesting a direct effect of adenovirus binding. Furthermore, blocking activation of the Raf/MAPK pathway with forskolin resulted in inhibition of IL-8 production. Up-regulation of IL-8 and other cytokines and chemokines could contribute significantly to the net inflammatory response to adenovirus infection [6] .
It was also shown that infection with adenovirus stimulates translocation of NF-κB to the nucleus [78, 79] . Activation of NF-κB could act to stimulate expression of pro-inflammatory genes with NF-κB-responsive elements in their promoter regions [79] . A number of viruses activate NF-κB and have evolved mechanisms to utilize various properties of NF-κB to facilitate gene expression, replication, and evasion of immune responses [80, 81] . Biphasic expression of NF-κB in the liver was seen after infusion of adenovirus in mice [78] . Early expression is not likely related to expression of adenoviral genes since activation occurred within 15 min after adenoviral infusion and was seen when viral E1, E2, E3 and L1-L4 regions were deleted [78] . However, later expression occurring 3 days after infusion is likely dependent on adenoviral genes since deletion of the above viral regions resulted in loss of NF-κB and expression of cytokines such as TNF-α [78] . We cannot exclude activation of NF-κB as a contributing factor to up-regulation of COX-2 in synovial cells following adenoviral infection [62] . Hirschowitz et al. found that NF-κB activity was not required for increased PGE 2 levels in non-small-cell lung cancer cells [63] .
Understanding the nature of the inflammatory reaction triggered directly by the process of adenovirus infection has important implications for the design and utilization of adenoviral-based vectors for human gene therapy. In addition to the possible use of recombinant adenovirus as a local or regional drug delivery system, a better understanding of the immune inflammatory activation phenomenon associated with contact of adenovirus with synovial cells may provide insight into synoviocytemediated events that may be involved in triggering viral-associated arthritis or other reactive arthridities.
